AMGEN INC Current Liabilities 2008-2026 | AMGN
Beta
What is current liabilities?
Current liabilities are obligations expected to be settled within one year or the normal operating cycle of the business.
What is AMGEN INC's current current liabilities?
AMGEN INC (AMGN) annual current liabilities for 2025 was $25.49B, a 10.35% increase from 2024. AMGEN INC current liabilities for the quarter ending March 31, 2026 was $24.95B.
What was AMGEN INC's current liabilities in 2024?
AMGEN INC annual current liabilities for 2024 was $23.10B, a 25.59% increase from 2023.
What was AMGEN INC's current liabilities in 2023?
AMGEN INC annual current liabilities for 2023 was $18.39B, a 17.24% increase from 2022.
What is AMGEN INC's 5-year current liabilities CAGR?
AMGEN INC current liabilities grew at a compound annual growth rate (CAGR) of 16.95% from FY2020 to FY2025, going from $11.65B to $25.49B over 5 years.
Current Liabilities History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Growing
CAGR+16.9%
FY2020
$11.65B
→
FY2025
$25.49B
080910111213141516171819202122232425
5 years selected
Current Liabilities History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $25.49B | +10.3% | 10-K |
| FY2024 | $23.10B | +25.6% | 10-K |
| FY2023 | $18.39B | +17.2% | 10-K |
| FY2022 | $15.69B | +28.8% | 10-K |
| FY2021 | $12.18B | +4.6% | 10-K |
| FY2020 | $11.65B | -9.2% | 10-K |
| FY2019 | $12.84B | -4.8% | 10-K |
| FY2018 | $13.49B | +49.5% | 10-K |
| FY2017 | $9.02B | -19.5% | 10-K |
| FY2016 | $11.20B | +29.3% | 10-K |
| FY2015 | $8.66B | +23.6% | 10-K |
| FY2014 | $7.01B | -11.8% | 10-K |
| FY2013 | $7.95B | -3.0% | 10-K |
| FY2012 | $8.19B | +42.4% | 10-K |
| FY2011 | $5.75B | -12.4% | 10-K |
| FY2010 | $6.57B | +69.6% | 10-K |
| FY2009 | $3.87B | -20.7% | 10-K |
| FY2008 | $4.89B | - | 10-K |
Company: AMGEN INCTicker: AMGNSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →